{"id":"doi:10.1111/cas.14069","kind":"review","title":"Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?","authors":["Yoshihiro Ohue","Hiroyoshi Nishikawa"],"author_count":2,"year":2019,"published":"2019-05-18","venue":"Cancer Science","cited_by":1042,"doi":"10.1111/cas.14069","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1111/cas.14069","archive_url":"https://space-kitty.com/papers/doi:10.1111/cas.14069","updated":null,"pmid":"31102428","pmcid":null,"openalex_id":"W2946663348","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.14069","abstract":null,"abstract_license":null,"license":"cc-by-nc","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["T-cell and B-cell Immunology"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}